Coronary heart disease with high LDL-C
Conditions
Interventions
treatment group:Atorvastatin 20mg qd po+qingzhihuayu 1 bid po
control group:Atorvastatin 20mg qd po+Placebo 1 bid po
Sponsors
Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Male or female aged 18-80 years; 2. Coronary angiography showed that more than 50% of any coronary artery stenosis was occurred; 3. LDL-C=1.8mmol/L; 4. Patients who are willing to receive atorvastatin treatment and traditional Chinese Medicine; 5. Written informed consent obtained.
Exclusion criteria
Exclusion criteria: 1. A history of statin related liver damage and / or muscle disease; 2. Patients with malignant tumors (excluding those who have been cured); 3. Combined with lung, kidney, brain, blood and other important organs of patients with serious diseases; 4. Patients with severe neurological and psychiatric diseases (such as epilepsy, depression, mania, epilepsy, schizophrenia, etc.); 5. Pregnant women and lactating women or patients who have pregnant schemes but were reluctant to use contraceptives during the study period; 6. Enrolled in another clinical study; 7. Patients who were not eligible for the study by the researchers' assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sdLDL-C;sdLDL-C/LDL-C; | — |
Secondary
| Measure | Time frame |
|---|---|
| LDL-C;TC;TG;HDL-C; | — |
Countries
China
Contacts
Public ContactZhou Hua
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed